Interra Health said it is expanding access to GLP-1 medications for Medicare patients via a $50-per-month Bridge program support offering. Separately, new sensor approaches continue pushing lab-grade performance toward the clinic, reflecting ongoing demand for faster, cheaper diagnostics that can operate outside large centralized labs.